Back to Journals » Drug Design, Development and Therapy » Volume 16 » Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation
Please verify you are not a robot.